The results revealed that ADGRG6 mRNA levels were elevated in several cancers when compared to the corresponding normal tissues, including CESC (cervical squamous cell carcinoma and endocervical adenocarcinoma), ESCA (Esophageal Cancer), GBM (Glioblastoma), KIRC (kidney renal clear cell carcinoma), KIRP (kidney renal papillary cell carcinoma), LGG (brain Lower Grade Glioma), OV (ovarian serous cystadenocarcinoma), PAAD (pancreatic adenocarcinoma), STAD (stomach adenocarcinoma), TGCT (testicular germ cell tumors), THYM (thymoma), and UCS (uterine carcinosarcoma) (Figure 1A). This evidence concerns the gene ADGRG6 and ovarian serous cystadenocarcinoma.